LANADELUMAB

Drug action

Lanadelumab is a humanised monoclonal antibody which inhibits plasma kallikrein activity, thereby limiting the production of bradykinin, a potent vasodilator associated with ang...

This item requires a subscription.
For full access to this content, log in to an existing user account or purchase an individual subscription.
×
Sign in or create an account
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. Sign in or purchase a subscription to access this content. ×